Find information on thousands of medical conditions and prescription drugs.

Tiagabine

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
Oxytetracycline
Phentermine
Tacrine
Tacrolimus
Tagamet
Talbutal
Talohexal
Talwin
Tambocor
Tamiflu
Tamoxifen
Tamsulosin
Tao
Tarka
Taurine
Taxol
Taxotere
Tazarotene
Tazobactam
Tazorac
Tegretol
Teicoplanin
Telmisartan
Temazepam
Temocillin
Temodar
Temodar
Temozolomide
Tenex
Teniposide
Tenoretic
Tenormin
Tenuate
Terazosin
Terbinafine
Terbutaline
Terconazole
Terfenadine
Teriparatide
Terlipressin
Tessalon
Testosterone
Tetrabenazine
Tetracaine
Tetracycline
Tetramethrin
Thalidomide
Theo-24
Theobid
Theochron
Theoclear
Theolair
Theophyl
Theophyl
Theostat 80
Theovent
Thiamine
Thiomersal
Thiopental sodium
Thioridazine
Thorazine
Thyroglobulin
Tiagabine
Tianeptine
Tiazac
Ticarcillin
Ticlopidine
Tikosyn
Tiletamine
Timolol
Timoptic
Tinidazole
Tioconazole
Tirapazamine
Tizanidine
TobraDex
Tobramycin
Tofranil
Tolazamide
Tolazoline
Tolbutamide
Tolcapone
Tolnaftate
Tolterodine
Tomoxetine
Topamax
Topicort
Topiramate
Tora
Toradol
Toremifene
Tracleer
Tramadol
Trandate
Tranexamic acid
Tranxene
Tranylcypromine
Trastuzumab
Trazodone
Trenbolone
Trental
Trest
Tretinoin
Triacetin
Triad
Triamcinolone
Triamcinolone hexacetonide
Triamterene
Triazolam
Triclabendazole
Triclosan
Tricor
Trifluoperazine
Trilafon
Trileptal
Trimetazidine
Trimethoprim
Trimipramine
Trimox
Triprolidine
Triptorelin
Tritec
Trizivir
Troglitazone
Tromantadine
Trovafloxacin
Tubocurarine chloride
Tussionex
Tylenol
Tyrosine
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


New drugs 98, part IV: Tiagabine HCI
From Nursing, 7/1/98 by Hussar, Daniel A

New adjunctive therapy option

Tiagabine HCl (Gabitril, Abbott) is the fifth drug to be marketed for treatment of partial seizures in the last 5 years. It's indicated as adjunctive therapy in adults and children 12 years and older. Tiagabine is thought to exert its antiseizure effect by increasing activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter.

As with other antiseizure drugs, CNS reactions are the most common adverse reactions. Potential problems include dizziness or light-headedness, asthenia, somnolence, nervousness or irritability, tremor, and difficulty with concentration or attention. Advise your patient not to engage in activities such as driving or operating machinery until she determines how the medication affects her. Also inform her that taking the medication concurrently with other drugs with CNS depressant activity can increase adverse reactions and suggest that she avoid alcoholic beverages. Other common adverse reactions, include nausea, vomiting, diarrhea, abdominal pain, and rash, including infrequent reports of serious rashes.

About 1% of patients in clinical studies experienced moderately severe to incapacitating generalized weakness, which resolved when the dosage was reduced or the drug discontinued.

Teach the patient to take tiagabine with food in divided doses two to four times daily. Warn her not to stop the drug without her physician's supervision. To prevent increased seizure activity, the dosage should be tapered gradually.

Tiagabine should be used during pregnancy only if clearly needed.

Tiagabine isn't available in Canada.

Copyright Springhouse Corporation Jul 1998
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Tiagabine
Home Contact Resources Exchange Links ebay